Carbamate compounds for use in preventing or treating anxiety disorders
a technology of carbamate compounds and anxiety disorders, applied in the direction of nervous disorders, biocide, drug compositions, etc., can solve the problems of side effects, sedation, impairment of cognition and psychomotor performance, and impairment of lifelong social development and occupational functioning, so as to prevent or treat anxiety disorders
Inactive Publication Date: 2005-12-01
PLATA SALAMAN CARLOS R +2
View PDF9 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
"The present invention is about a new method for treating anxiety disorders using certain compounds. These compounds are believed to have a therapeutic effect by interacting with specific receptors in the body. The invention includes a method for using these compounds in a pharmaceutical composition to treat anxiety disorders. The invention also includes the use of specific enantiomers of the compounds. The technical effect of this invention is to provide a more effective treatment for anxiety disorders using specific compounds and their enantiomers."
Problems solved by technology
Social phobia, if left untreated, will become associated with extensive morbidity and disability, leading to lifelong impairment in social development and occupational functioning.
Currently marketed drugs such as clonazepam and diazepam can relieve symptoms, but they also have side effects that are characteristic of the benzodiazepine class of drugs (that is, sedation and impairment of cognition and psychomotor performance).
Acute psychological stress is the presumed immediate cause of PTSD, resulting in physiologic hyperarousal (startle reactions, intrusive thoughts, illusions, overgeneralized associations, sleep problems, nightmares, dreams about the precipitating event, impulsivity, difficulties in concentration, and hyper-alertness).
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0024] The present invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II):
wherein [0025] phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, [0026] R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
[0027] The present method includes the use of a compound selected from the group consisting of Formula (I) and Formula (II) wherein X is chlorine; preferably, X is substituted at the ortho position of the phenyl ring.
[0028]...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
| Property | Measurement | Unit |
|---|---|---|
| anxiety disorder | aaaaa | aaaaa |
| stress | aaaaa | aaaaa |
| posttraumatic stress disorder | aaaaa | aaaaa |
Login to View More
Abstract
This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Description
CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims benefit of provisional application Ser. No. 60 / 271,689, filed 27 Feb. 2001, which is hereby incorporated by reference.FIELD OF THE INVENTION [0002] This invention is directed to a method for use of a carbamate compound in preventing or treating anxiety disorders. More particularly, this invention is directed to a method for use of halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate compounds for preventing or treating anxiety disorders. BACKGROUND OF THE INVENTION [0003] Anxiety disorders, one of the most prevalent psychiatric illnesses in the general community, represents a group of emotional states consisting of psychophysiological responses to anticipation of unreal or imagined danger which are not a result of physical disorders, drug abuse or other psychiatric conditions (Anxiety Overview, Market Research Reports, 2001; Briley M and Moret C, Present and Future Anxiolytics, Drugs, 2000, 3 (7), 695...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/27A61P25/20A61P25/22A61P43/00
CPCA61K31/27A61P25/00A61P25/18A61P25/20A61P25/22A61P43/00A61K31/325
Inventor PLATA-SALAMAN, CARLOS R.ZHAO, BOYUTWYMAN, ROY E.
Owner PLATA SALAMAN CARLOS R